← Leaderboards
Neehar Dilip Parikh
University Of Michigan At Ann Arbor
$2,316,206
Attributed
$6,497,704
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,497,704 · 2
By mechanism
U01$6,497,704 · 2
Top collaborators
- Elliot Tapper5 shared
- Fasiha Kanwal4 shared
- Jorge A Marrero4 shared
- Amit Singal4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Elliot Tapper$2,159,285
- Pratima Sharma$927,372
- Anna Sf Lok$10,814,527
- Lona Mody$10,883,116
- Grace L. Su$1,532,222
Others in their field
Other Emerging Leaders on “Cirrhosis”
- Amit Singal · Ut Southwestern Medical Center$15,105,435
- Marina Serper · University Of Pennsylvania$7,301,871
- Cynthia A Moylan · Duke University$5,972,949
- Valerian Nakaar · Carogen Corporation$4,718,929
- Jody D. Ciolino · Northwestern University At Chicago$4,372,157
- Yazhen Zhu · University Of California Los Angeles$4,089,586
Research focus
CirrhosisBloodFundingResourcesClinical RiskHigh RiskCohortEtiologyProspectivePrimary Carcinoma Of The Liver CellsRisk StratificationPatient PopulationBiological MarkersLiverClinical PracticeCessation Of LifeLiver DiseasesAlcohol AbuseCollectionCaregiversCardiovascular SystemAlcohol Use DisorderChildComplex
Grant awards (9)
Clinical Validation Center for Hepatocellular Carcinoma$893,833
U01 · FY2025 · CA
Statin Therapy for patients with compensated Cirrhosis$613,662
U01 · FY2025 · DK
Clinical Validation Center for Hepatocellular Carcinoma$1,007,940
U01 · FY2024 · CA
Statin Therapy for patients with compensated Cirrhosis$441,673
U01 · FY2024 · DK
Clinical Validation Center for Hepatocellular Carcinoma$1,041,376
U01 · FY2023 · CA
Statin Therapy for patients with compensated Cirrhosis$703,876
U01 · FY2023 · DK
Clinical Validation Center for Hepatocellular Carcinoma$787,434
U01 · FY2022 · CA
Statin Therapy for patients with compensated Cirrhosis$641,566
U01 · FY2022 · DK
Statin Therapy for patients with compensated Cirrhosis$366,344
U01 · FY2021 · DK